Funding · Company

Newleos Therapeutics, Inc.

Boston, MABiotech & Pharma

Newleos Therapeutics, Inc. of Boston, MA has disclosed $93M across 1 Form D offering filed with the SEC on Feb 24, 2025.

$93M

Total disclosed

Form D offering

2024

Incorporated

Offerings on file

Each amount is as reported on that filing, cumulative across its own amendments. Newest first.

$93M

Form D · Feb 24, 2025 ↗

Q1 2025

Filing details

HeadquartersBoston, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2024SEC CIK0002057800Offerings on file1

Links

All SEC filings for this company ↗ newleostherapeutics.com ↗ Startups in Boston → More biotech & pharma raises →

Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →